Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MY-008 by Createrna Science and Technology for IgA Nephropathy (Berger's Disease): Likelihood of Approval
MY-008 is under clinical development by Createrna Science and Technology and currently in Phase II for IgA Nephropathy (Berger's Disease)....
Data Insights
MY-008 by Createrna Science and Technology for IgA Nephropathy (Berger's Disease): Likelihood of Approval
MY-008 is under clinical development by Createrna Science and Technology and currently in Phase I for IgA Nephropathy (Berger's Disease)....